Share
TRUEinvivo is pleased to announce that it went live on the SyndicateRoom investment platform on 27th February 2019. This enables the company to be visible to the wide network of potential investors who are registered with SyndicateRoom. The company chose SyndicateRoom as its online investment partner because of its excellent reputation in the equity crowdfunding market, its high levels of vetting and due diligence, and the professional help it gives its clients to present themselves well. SyndicateRoom joins TRUEinvivo’s offline investment network partner Nexus Investment Ventures Ltd (NIVL) in connecting TRUEinvivo with High Net Worth or Sophisticated potential investors. Note that this is an information news post and is not an invitation to invest in the company.
Related Posts
TRUEinvivo® receives CE Mark for DOSEmapper Reader, automating radiotherapy dose measurement for enhanced accuracy.
Dr. Shakardokht Jafari named 2024 Innovator of the Year at Dynamic Awards in Brighton's Grand Hotel.
TRUEinvivo's 2018 achievements include prototype development, patent filings, fundraising, multiple awards, and market expansion, setting the stage for a busy 2019.
This order is for a number of DOSEmapper™ devices and for our DOSEmapper™ Bead Reading Service.
